Johnson & Johnson (NYSE: JNJ) is reportedly preparing for a potential sale of its orthopedics unit, DePuy Synthes, as it advances plans to separate the business. In 2011, the medtech giant acquired ...

(Bloomberg) --Johnson & Johnson is preparing a potential sale of the orthopedics unit that it has been planning to separate, with big buyout firms already circling, according to people familiar with ...

DePuy Synthes has a well established reputation in the inpatient and hospital outpatient department setting. Now, the company is developing a new focus on freestanding ambulatory surgery centers: ...

Andrie Leday joined DePuy Synthes, Johnson and Johnson’s orthopedic company, as its vice president of the ASC division in August, following 12 years at Medtronic. Mr. Leday joined the company with a ...

Johnson & Johnson plans to spin off its orthopedics business into a standalone company. The move comes as part of a bid to focus J&J’s medical technology division on faster-growing areas. In an Oct.